litlas
Log inCreate account

Irvin M. Modlin

Active 1976–2024

95
Papers
21,842
Citations
80
h-index
95
i10-index

Citations

Citations per year for Irvin M. Modlin1976: 3 citations1977: 25 citations1978: 28 citations1979: 19 citations1980: 27 citations1981: 11 citations1982: 8 citations1983: 13 citations1984: 4 citations1985: 7 citations1986: 1 citations1987: 8 citations1989: 1 citations1990: 2 citations1991: 1 citations1992: 7 citations1993: 11 citations1994: 12 citations1995: 12 citations1996: 14 citations1997: 26 citations1998: 35 citations1999: 38 citations2000: 40 citations2001: 51 citations2002: 50 citations2003: 78 citations2004: 64 citations2005: 87 citations2006: 119 citations2007: 123 citations2008: 138 citations2009: 119 citations2010: 182 citations2011: 175 citations2012: 140 citations2013: 121 citations2014: 150 citations2015: 164 citations2016: 135 citations2017: 168 citations2018: 130 citations2019: 571 citations2020: 554 citations2021: 417 citations2022: 277 citations2023: 173 citations2024: 295 citations2025: 78 citations2026: 2 citations1988: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,378 citing papers, 26.6% of this breakdownItaly: 409 citing papers, 7.9% of this breakdownGermany: 400 citing papers, 7.7% of this breakdownUnited Kingdom: 360 citing papers, 6.9% of this breakdownChina: 272 citing papers, 5.2% of this breakdownFrance: 225 citing papers, 4.3% of this breakdownNetherlands: 215 citing papers, 4.2% of this breakdownSweden: 210 citing papers, 4.1% of this breakdownJapan: 162 citing papers, 3.1% of this breakdownSwitzerland: 144 citing papers, 2.8% of this breakdownCanada: 131 citing papers, 2.5% of this breakdownSpain: 115 citing papers, 2.2% of this breakdown
0%26.6%Other 22.5%

Institutions

Fields

  • Medicine78.4%
  • Biochemistry, Genetics and Molecular Biology9%
  • Neuroscience5.6%
  • Immunology and Microbiology3.9%
  • Nursing1.1%
  • Computer Science0.5%
  • Other1.5%

Topics

  • Neuroendocrine Tumor Research Advances17.8%
  • Lung Cancer Research Studies11.4%
  • Neuroblastoma Research and Treatments7%
  • Pancreatic and Hepatic Oncology Research4.4%
  • Gastrointestinal Tumor Research and Treatment3%
  • Neuropeptides and Animal Physiology1.9%
  • Other54.5%

Coauthors

All papers

Open in search
  1. Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors

    Authors: Lisa Bodei, Mark Kidd, Giovanni Paganelli, Chiara Maria Grana, Ignat Drozdov, Marta Cremonesi, Christopher Lepensky, Dik J. Kwekkeboom, Richard P. Baum, Eric P. Krenning, Irvin M. Modlin - European Journal of Nuclear Medicine and Molecular Imaging 2014 cited by 466

  2. A 5‐decade analysis of 13,715 carcinoid tumors

    Authors: Irvin M. Modlin, Kevin D. Lye, Mark Kidd - Cancer 2003 cited by 2,748

  3. Gastroenteropancreatic neuroendocrine tumours

    Authors: Irvin M. Modlin, Kjell Öberg, Daniel C. Chung, Robert T. Jensen, Wouter W. de Herder, Rajesh V. Thakker, Martyn Caplin, Gianfranco Delle Fave, Gregory Kaltsas, Eric P. Krenning, Steven F. Moss, Ola Nilsson, Guido Rindi, Ramón Salazar, Philippe Ruszniewski, Anders Sundin - The Lancet Oncology 2008 cited by 1,752

  4. A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors

    Authors: Mariano J. Alvarez, Prem S. Subramaniam, Laura H. Tang, Adina Grunn, Mahalaxmi Aburi, Gabrielle E. Rieckhof, Elena V. Komissarova, Elizabeth Hagan, Lisa Bodei, Paul A. Clemons, Filemon S. Dela Cruz, Deepti Dhall, Daniel Diolaiti, Douglas A. Fraker, Afshin Ghavami, Daniel Kaemmerer, Charles Karan, Mark Kidd, Kyoung M. Kim, Hee C. Kim, Lakshmi P. Kunju, Ülo Langel, Zhong Li, Jeeyun Lee, Hai Li, Virginia A. LiVolsi, Roswitha Pfragner, Allison R. Rainey, Ronald Realubit, Helen Remotti, Jakob Regberg, Robert E. Roses, Anil K. Rustgi, Antonia R. Sepulveda, Stefano Serra, Chanjuan Shi, Xiaopu Yuan, Massimo Barberis, Roberto Bergamaschi, Arul M. Chinnaiyan, Tony Detre, Shereen Ezzat, Andrea Frilling, Merten Hommann, Dirk Jaeger, Michelle K. Kim, Beatrice S Knudsen, Andrew L. Kung, Emer Leahy, David C. Metz, Jeffrey W. Milsom, Young Shin Park, Diane Reidy‐Lagunes, Stuart L. Schreiber, Kay Washington, Bertram Wiedenmann, Irvin M. Modlin, Andrea Califano - Nature Genetics 2018 cited by 226

  5. Consensus on biomarkers for neuroendocrine tumour disease

    Authors: Kjell Öberg, Irvin M. Modlin, Wouter W. de Herder, Marianne Pavel, David S. Klimstra, Andrea Frilling, David C. Metz, Anthony P. Heaney, Dik J. Kwekkeboom, Jonathan Strosberg, T Meyer, Steven F. Moss, Kay Washington, Edward M. Wolin, Eric Liu, James R. Goldenring - The Lancet Oncology 2015 cited by 280

  6. The Epidemiology of Gastroenteropancreatic Neuroendocrine Tumors

    Authors: Ben Lawrence, Björn Gustafsson, Anthony Chan, Bernhard Svejda, Mark Kidd, Irvin M. Modlin - Endocrinology and Metabolism Clinics of North America 2011 cited by 857

  7. PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest

    Authors: Lisa Bodei, Mark Kidd, Aviral Singh, Wouter A. van der Zwan, Stefano Severi, Ignat Drozdov, Anna Malczewska, Richard P. Baum, Dik J. Kwekkeboom, Giovanni Paganelli, Eric P. Krenning, Irvin M. Modlin - European Journal of Nuclear Medicine and Molecular Imaging 2019 cited by 105

  8. Recommendations for management of patients with neuroendocrine liver metastases

    Authors: Andrea Frilling, Irvin M. Modlin, Mark Kidd, Christopher Russell, Stefan Breitenstein, Riad Salem, Dik J. Kwekkeboom, Wan-Yee Lau, Catherine Klersy, Valérie Vilgrain, Brian R Davidson, Mark Siegler, Martyn Caplin, Enrico Solcia, Richard L. Schilsky - The Lancet Oncology 2014 cited by 516

  9. Luminal regulation of normal and neoplastic human EC cell serotonin release is mediated by bile salts, amines, tastants, and olfactants

    Authors: Mark Kidd, Irvin M. Modlin, Björn Gustafsson, Ignat Drozdov, Øyvind Hauso, Roswitha Pfragner - American Journal of Physiology-Gastrointestinal and Liver Physiology 2008 cited by 236

  10. Mediation of the trophic effects of short-chain fatty acids on the rat jejunum and colon

    Authors: Wendy L. Frankel, Wel Zhang, Anudeep Singh, David M. Klurfeld, Sidney H. Don, Takashi Sakata, Irvin M. Modlin, John L. Rombeau - Gastroenterology 1994 cited by 220

  11. PRRT genomic signature in blood for prediction of 177Lu-octreotate efficacy

    Authors: Lisa Bodei, Mark Kidd, Aviral Singh, Wouter A. van der Zwan, Stefano Severi, Ignat Drozdov, Jarosław B. Ćwikła, Richard P. Baum, Dik J. Kwekkeboom, Giovanni Paganelli, Eric P. Krenning, Irvin M. Modlin - European Journal of Nuclear Medicine and Molecular Imaging 2018 cited by 131

  12. Neuroendocrine Neoplasms of the Small Bowel and Pancreas

    Authors: Ashley Kieran Clift, Mark Kidd, Lisa Bodei, Christos Toumpanakis, Richard P. Baum, Kjell Öberg, Irvin M. Modlin, Andrea Frilling - Neuroendocrinology 2019 cited by 121

  13. The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors

    Authors: Anna Malczewska, Beata Kos‐Kudła, Mark Kidd, Ignat Drozdov, Lisa Bodei, Somer Matar, Kjell Öberg, Irvin M. Modlin - Advances in Medical Sciences 2019 cited by 58

  14. A multigenomic liquid biopsy biomarker for neuroendocrine tumor disease outperforms CgA and has surgical and clinical utility

    Authors: Irvin M. Modlin, Mark Kidd, Massimo Falconi, Pier Luigi Filosso, Andrea Frilling, Anna Malczewska, Christos Toumpanakis, Gerlof D. Valk, Karel Pacák, Lisa Bodei, Kjell E. Öberg - Annals of Oncology 2021 cited by 49

  15. Current Status of Gastrointestinal Carcinoids

    Authors: Irvin M. Modlin, Mark Kidd, Igor Latich, Michelle N. Zikusoka, Michael D. Shapiro - Gastroenterology 2005 cited by 851

  16. Chromogranin A—Biological Function and Clinical Utility in Neuro Endocrine Tumor Disease

    Authors: Irvin M. Modlin, Björn Gustafsson, Steven F. Moss, Marianne Pavel, Apostolos V. Tsolakis, Mark Kidd - Annals of Surgical Oncology 2010 cited by 387

  17. The NETest

    Authors: Irvin M. Modlin, Mark Kidd, Anna Malczewska, Ignat Drozdov, Lisa Bodei, Somer Matar, Kyung-Min Chung - Endocrinology and Metabolism Clinics of North America 2018 cited by 123

  18. NET Blood Transcript Analysis Defines the Crossing of the Clinical Rubicon: When Stable Disease Becomes Progressive

    Authors: Marianne Pavel, Henning Jann, Vikas Prasad, Ignat Drozdov, Irvin M. Modlin, Mark Kidd - Neuroendocrinology 2016 cited by 112

  19. Objective Quantification of the Ki67 Proliferative Index in Neuroendocrine Tumors of the Gastroenteropancreatic System

    Authors: Laura H. Tang, Mithat Gönen, Cyrus V. Hedvat, Irvin M. Modlin, David S. Klimstra - The American Journal of Surgical Pathology 2012 cited by 254

  20. The Identification of Gut Neuroendocrine Tumor Disease by Multiple Synchronous Transcript Analysis in Blood

    Authors: Irvin M. Modlin, Ignat Drozdov, Mark Kidd - PLoS ONE 2013 cited by 165

  21. Circulating Transcript Analysis (NETest) in GEP-NETs Treated With Somatostatin Analogs Defines Therapy

    Authors: Jarosław B. Ćwikła, Lisa Bodei, Agnieszka Kolasińska-Ćwikła, A Sankowski, Irvin M. Modlin, Mark Kidd - The Journal of Clinical Endocrinology & Metabolism 2015 cited by 124

  22. The Clinical Utility of a Novel Blood-Based Multi-Transcriptome Assay for the Diagnosis of Neuroendocrine Tumors of the Gastrointestinal Tract

    Authors: Irvin M. Modlin, Mark Kidd, Lisa Bodei, Ignat Drozdov, Harry R. Aslanian - The American Journal of Gastroenterology 2015 cited by 94

  23. Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy

    Authors: Lisa Bodei, Heiko Schöder, Richard P. Baum, Ken Herrmann, Jonathan Strosberg, Martyn Caplin, Kjell Öberg, Irvin M. Modlin - The Lancet Oncology 2020 cited by 75

  24. Neuroendocrine Tumors of the Gallbladder

    Authors: Karim M. Eltawil, Björn Gustafsson, Mark Kidd, Irvin M. Modlin - Journal of Clinical Gastroenterology 2010 cited by 183